株式会社AIメディカルサービス
AI Medical Service develops AI software that helps clinicians detect early-stage cancers and polyps in the digestive tract using endoscopic images. The company delivers a SaaS platform and diagnostic models—including gastroAI model-G2 and gastroAI model-EIRL—that apply deep learning and image-recognition techniques to interpret screening images. Its technology integrates with endoscopy workflows used by hospitals and clinics to provide real-time or retrospective lesion detection and diagnostic support. Target customers are healthcare providers and medical institutions specializing in gastroenterology. The company partners with over 100 medical institutions and is expanding its international footprint to scale clinical adoption.
株式会社AIメディカルサービス
AI Medical Service develops AI software that helps clinicians detect early-stage cancers and polyps in the digestive tract using endoscopic images. The company delivers a SaaS platform and diagnostic models—including gastroAI model-G2 and gastroAI model-EIRL—that apply deep learning and image-recognition techniques to interpret screening images. Its technology integrates with endoscopy workflows used by hospitals and clinics to provide real-time or retrospective lesion detection and diagnostic support. Target customers are healthcare providers and medical institutions specializing in gastroenterology. The company partners with over 100 medical institutions and is expanding its international footprint to scale clinical adoption.